BusinessRadius Health to Present at ENDO 2018 Including Results of the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) InjectionBy Nasdaq OMXMar 12, 2018, 8:30 PM UTC
BusinessNewLink Genetics to Participate in Upcoming Investor ConferencesBy Nasdaq OMXMar 12, 2018, 1:01 PM UTC
BusinessArbutus Announces Conference Call to Provide a Corporate Update and Fourth Quarter 2017 Year-End Financial ResultsBy Nasdaq OMXMar 12, 2018, 1:00 PM UTC
BusinessImmune Design Reports Data Update for Lead Immunotherapy Programs: Improvement in Survival for CMB305 Monotherapy in Sarcoma and Increased Objective Responses for G100/pembrolizumab Combination in Follicular LymphomaBy Nasdaq OMXMar 12, 2018, 12:01 PM UTC
BusinessPivot Pharma Retains Cannabis Compliance to File Dealer’s License Application on Behalf of Agro-Biotech Inc.By Nasdaq OMXMar 12, 2018, 7:30 AM UTC
BusinessAquaBounty Technologies, Inc. Results for the year ended December 31, 2017By Nasdaq OMXMar 8, 2018, 9:30 PM UTC
BusinessCapricor Therapeutics to Present Fourth Quarter and Full Year 2017 Financial Results and Corporate Update on Wednesday, March 14By Nasdaq OMXMar 8, 2018, 9:00 PM UTC
